Results 111 to 120 of about 11,166,985 (272)

Engineering Art [PDF]

, 2000
Manforte, Tracy
core   +4 more sources

Innovation Engineering [PDF]

, 2001
Tershak, Irina, Borshch, T.V., Zaika, L.A.   +2 more
core   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Table of Contents

Engineering Transactions, 2013
Engineering Transactions Engineering Transactions
doaj   +2 more sources

Retraction Note: Double-negative metamaterial square enclosed Q.S.S.R For microwave sensing application in S-band with high sensitivity and Q-factor. [PDF]

Sci Rep
Khalil MA, Yong WH, Islam MT, Hoque A, Islam MS, Leei CC, Soliman MS.   +6 more
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Erratum to "Heterogeneity-Aware, Multiscale Annotation of Shared and Specific Neurobiological Signatures among Major Neurodevelopmental Disorders". [PDF]

Research (Wash D C)
Diao Y, Huang Y, Zhu B, Guo M, Wang W, Li Z, Li W, Zhang H, Zhou J, Li X, Wu F, Wu K.   +11 more
europepmc   +1 more source

Sound Commentary: Reply [PDF]

, 2008
Everbach, E. Carr
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Retraction Note: Strategical selection of maintenance type under different conditions. [PDF]

Sci Rep
Hamasha MM, Bani-Irshid AH, Al Mashaqbeh S, Shwaheen G, Al Qadri L, Shbool M, Muathen D, Ababneh M, Harfoush S, Albedoor Q, Al-Bashir A.   +10 more
europepmc   +1 more source